Business
Interim Results of Independent Evaluation Confirm That Microbix' Flu Vaccine Technology Works
Interim Results of Independent Evaluation Confirm That Microbix' Flu Vaccine Technology Works.
About this update from Microbix Biosystems Inc.
[{"type":"text","content":"\n\n\n\n\nTORONTO, March 14 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) announces\nthat interim findings of an independent evaluation have confirmed that its\nproprietary technology delivers a significant increase in the yield of\ninfluenza virus used in the manufacture of flu vaccine.\nThe independent laboratory found that Microbix' technology results in\nmore than a two-fold increase in the amount of human influenza virus produced\nthrough conventional industry methods. More experiments are scheduled, and the\nCompany expects to announce final results in the near future.\nOnce this phase is completed, the study will focus on the application of\nthe technology to avian flu virus, which should be completed this summer.\n\"We're pleased with these results to date showing that our technology\nholds the promise of being able to produce flu vaccine in greater quantities\nthan ever before,\" said Microbix President and CEO William J. Gastle.\n\"When validated by the final results, this would be an important\nbreakthrough because world capacity for the production of flu vaccine is\ninadequate today,\" Gastle stated. \"Our technology would aid in more people\nbeing protected against influenza in the future. It would give vaccine\nmanufacturers enhanced production yields to respond to widespread influenza\noutbreaks and new virus strains.\"\n\nMicrobix specializes in developing proprietary biological technologies\nand commercializing them through global partners. The Company has intellectual\nproperty in large market biotherapeutic drugs, vaccine technologies and animal\nreproduction technologies. Established in 1988, Microbix is headquartered in\nToronto.\n\nThis press release contains forward-looking statements, which are subject\nto risks and uncertainties that could cause actual results to differ\nmaterially from those set forth in the forward-looking statements. These\nforward-looking statements represent the Company's judgment as of the date of\nthis press release. The Company disclaims any intent or obligation to update\nthese forward-looking statements.\n%SEDAR: 00004220E\n\n\n","length":2143,"tagName":"div"}]